-+ 0.00%
-+ 0.00%
-+ 0.00%

ANGIODYNAMICS RECEIVES FDA IDE APPROVAL FOR RELIEF FEASIBILITY STUDY EVALUATING NANOKNIFE IRE PLATFORM AS MINIMALLY INVASIVE TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA (BPH)

Reuters·06/17/2026 12:30:05

Please log in to view news